BeOne Medicines AG (BVMF:B1ME34)
Brazil · Delayed Price · Currency is BRL 66.50
-5.40 (-7.51%)
At close: Nov 5, 2025
BeOne Medicines AG Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 488.02 | -4,706 | -6,252 | -13,821 | -9,261 | -10,609 | Upgrade |
Depreciation & Amortization | 1,042 | 1,219 | 595.18 | 434.89 | 288.99 | 207.54 | Upgrade |
Other Amortization | 68.64 | 34.52 | 26.51 | 22.24 | 6.13 | - | Upgrade |
Asset Writedown & Restructuring Costs | -254.62 | -96.54 | -60.23 | -191.31 | -184.14 | -29.29 | Upgrade |
Loss (Gain) From Sale of Investments | 414.61 | 175.34 | 115.02 | 151.71 | -48.48 | -77.21 | Upgrade |
Stock-Based Compensation | 3,522 | 3,223 | 2,607 | 2,091 | 1,529 | 1,198 | Upgrade |
Other Operating Activities | 250.77 | 271.13 | -2,611 | 76.6 | 170.8 | -52.42 | Upgrade |
Change in Accounts Receivable | -2,086 | -2,405 | -1,335 | 2,098 | -2,687 | 67.66 | Upgrade |
Change in Inventory | -726.49 | -667.84 | -999.45 | -391 | -974.06 | -384.57 | Upgrade |
Change in Accounts Payable | 716.05 | 886.82 | 152.34 | -30.02 | 127.1 | 625.67 | Upgrade |
Change in Unearned Revenue | 4.51 | 4.62 | -1,812 | -1,047 | 2,590 | - | Upgrade |
Change in Other Net Operating Assets | 2,152 | 1,034 | 1,367 | 283.72 | 192.46 | 674.35 | Upgrade |
Operating Cash Flow | 5,591 | -1,026 | -8,207 | -10,322 | -8,250 | -8,379 | Upgrade |
Capital Expenditures | -1,714 | -3,596 | -3,984 | -2,245 | -1,670 | -767.16 | Upgrade |
Sale (Purchase) of Intangibles | -574.46 | -266.23 | -243.68 | -990.89 | -329.76 | -714.88 | Upgrade |
Investment in Securities | -122.49 | -119.35 | 4,668 | 10,675 | 6,070 | -19,190 | Upgrade |
Other Investing Activities | 51.75 | -20.89 | -14.71 | -10.24 | - | -13.22 | Upgrade |
Investing Cash Flow | -2,359 | -4,002 | 425.48 | 7,429 | 4,070 | -20,685 | Upgrade |
Short-Term Debt Issued | - | 6,338 | 4,691 | 2,164 | 2,582 | 2,113 | Upgrade |
Long-Term Debt Issued | - | 66.08 | 159.56 | 257.76 | 106.97 | 719.5 | Upgrade |
Total Debt Issued | 5,449 | 6,404 | 4,850 | 2,422 | 2,689 | 2,833 | Upgrade |
Short-Term Debt Repaid | - | -5,140 | -2,195 | -2,877 | -2,044 | -79.96 | Upgrade |
Long-Term Debt Repaid | - | -204.6 | -97.07 | - | - | -862.17 | Upgrade |
Total Debt Repaid | -6,080 | -5,345 | -2,292 | -2,877 | -2,044 | -942.13 | Upgrade |
Net Debt Issued (Repaid) | -631.05 | 1,059 | 2,558 | -454.77 | 645 | 1,891 | Upgrade |
Issuance of Common Stock | 1,323 | 331.18 | 395.05 | 323.92 | 22,459 | 28,237 | Upgrade |
Other Financing Activities | 6,300 | 21.9 | - | - | - | 3,840 | Upgrade |
Financing Cash Flow | 6,820 | 1,412 | 2,953 | -130.85 | 23,104 | 33,967 | Upgrade |
Foreign Exchange Rate Adjustments | -105.73 | -377.4 | -57.31 | -478.55 | 89.16 | 119.02 | Upgrade |
Net Cash Flow | 9,946 | -3,994 | -4,886 | -3,503 | 19,013 | 5,022 | Upgrade |
Free Cash Flow | 3,877 | -4,622 | -12,192 | -12,567 | -9,921 | -9,146 | Upgrade |
Free Cash Flow Margin | 10.95% | -16.62% | -69.93% | -128.68% | -132.76% | -453.57% | Upgrade |
Free Cash Flow Per Share | 34.83 | -43.90 | -116.79 | -121.85 | -106.92 | -109.57 | Upgrade |
Cash Interest Paid | 349.99 | 373.53 | 140.07 | 173.6 | 190.37 | 288.11 | Upgrade |
Cash Income Tax Paid | 673.58 | 506.78 | 397.11 | 203.47 | 99.7 | 69.18 | Upgrade |
Levered Free Cash Flow | 2,490 | -2,679 | -9,034 | -6,509 | -7,648 | -4,911 | Upgrade |
Unlevered Free Cash Flow | 2,607 | -2,612 | -9,015 | -6,426 | -7,536 | -4,838 | Upgrade |
Change in Working Capital | 60.4 | -1,147 | -2,627 | 913.13 | -751.8 | 983.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.